$EXPO

James Bradley A sold $115K of EXPO

James Bradley A (Group Vice President) sold 2,000 shares of EXPONENT INC (EXPO) at $57.46 ($0.11M total) on 2026-05-26.

Original reporting
SEC EDGAR · James Bradley A
Published May 27, 2026, 4:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 4:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EXPO
Bearish
medium confidence
Mentioned
$EXPO
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXPOBearishMed
01

Why it matters

Traders may react to insider selling as a sentiment input, but the filing lacks any fundamental update (no earnings, guidance, deal, or regulatory action).

02

Market read

Expect a modest, short-term sentiment effect for EXPO around the disclosure; longer-term direction likely depends on upcoming fundamentals rather than this transaction.

03

What to watch

No 10b5-1 plan is cited, but Form 4s often omit intent; also, the post-trade holdings remain substantial (1,105 shares), suggesting no full exit.

Relevance 7/10Timing: Immediate (filed 2026-05-27; trade impact most likely around the disclosure window).

Background

The article is a SEC Form 4 insider transaction disclosure for Exponent Inc, showing an officer/direct sale of company shares.

Company-level read

Ticker impact

$EXPOBearishMedium confidence
Context

Exponent Inc (EXPO) disclosed an officer open-market sale: 2,000 shares sold at $57.4650 on 2026-05-26 via SEC Form 4.

Expected impact

Likely mild, short-lived downside bias around the filing date; no clear fundamental catalyst indicated.

Evidence & confidence

This is an ownership-change disclosure (Form 4) with no accompanying operational or financial news; absence of a stated 10b5-1 plan increases interpretation risk but does not prove bearish fundamentals.

Market effects

Limited read-across; insider Form 4s are usually company-specific sentiment signals rather than sector catalysts.

None indicated; filing is US SEC EDGAR with no regional macro linkage.

None indicated; no international deal/regulatory/earnings content.

Counterpoint

The sale could be routine diversification or tax-related; without context, it may not reflect a change in outlook.

Key entities

  • Exponent Inc

    Subject of the Form 4 insider sale by James Bradley A (Group Vice President).

  • James Bradley A

    Exponent officer who sold 2,000 shares at $57.4650 on 2026-05-26.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EXPOMedAI 8/10

What Exponent (EXPO) Said on Its Q3 Earnings Call

Exponent (EXPO) reported $171M in stock buybacks over the past year, reducing shares outstanding by 5%. Q3 saw $14.7M in dividends. Revenue grew 13% in engineering, 3% in environmental/health. AI-related work is 15-20% of business. Q4 outlook: 8-10% revenue growth, 26.3-26.8% EBITDA margin. Full-year 2026 outlook raised: 10-11% revenue growth, 28-28.3% EBITDA margin.